Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema. | Clin Transl Allergy | 2023 | 38006386 | PubTator, text mining | PubMed |
| Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. | Nat Commun | 2023 | 37978175 | PubTator, text mining | PubMed |
| Endothelial cell dysfunction in cardiac disease: driver or consequence? | Front Cell Dev Biol | 2023 | 37965580 | PubTator, text mining | PubMed |
| Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins. | J Virol | 2023 | 37931130 | PubTator, text mining | PubMed |
| Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. | J Chem Inf Model | 2023 | 37910792 | PubTator, text mining | PubMed |
| Visualizing vasculature and its response to therapy in the tumor microenvironment. | Theranostics | 2023 | 37908739 | PubTator, text mining | PubMed |
| Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis. | Cancers (Basel) | 2023 | 37894474 | PubTator, text mining | PubMed |
| Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study. | J Am Heart Assoc | 2023 | 37889181 | PubTator, text mining | PubMed |
| Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection. | bioRxiv | 2023 | 37886542 | PubTator, text mining | PubMed |
| Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review. | Pulm Circ | 2023 | 37868718 | PubTator, text mining | PubMed |
| uAUG creating variants in the 5'UTR of ENG causing Hereditary Hemorrhagic Telangiectasia. | NPJ Genom Med | 2023 | 37848456 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers. | Monoclon Antib Immunodiagn Immunother | 2023 | 37824755 | PubTator, text mining | PubMed |
| Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation? | Front Oncol | 2023 | 37823054 | PubTator, text mining | PubMed |
| Proteomics of CKD progression in the chronic renal insufficiency cohort. | Nat Commun | 2023 | 37816758 | PubTator, text mining | PubMed |
| In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. | Genomics Inform | 2023 | 37813626 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood-brain barrier integrity. | Proc Natl Acad Sci U S A | 2023 | 37796990 | PubTator, text mining | PubMed |
| Pre-arterialization of coronary veins prior to retroperfusion of ischemic myocardium: percutaneous closure device. | Front Cardiovasc Med | 2023 | 37790598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=10